<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00431223</url>
  </required_header>
  <id_info>
    <org_study_id>05I/C52</org_study_id>
    <nct_id>NCT00431223</nct_id>
  </id_info>
  <brief_title>Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training</brief_title>
  <acronym>fMRI</acronym>
  <official_title>Does Computerized Cognitive Skills Training Change Brain Activation Patterns in Schizophrenia?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Manhattan Psychiatric Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nathan Kline Institute for Psychiatric Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Manhattan Psychiatric Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is a novel exploratory research project to investigate changes in activation&#xD;
      patterns of the dorsolateral prefrontal cortex (DLPFC) in inpatients with schizophrenia who&#xD;
      received a 12-week computerized cognitive remediation (CRT) program. The hypothesis is that&#xD;
      patients receiving CRT will show greater increase in activation patterns in the brain as&#xD;
      compared to controls, and the degree of brain activation will correlate with improvements in&#xD;
      working memory.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Abnormalities in the domains of attention, working memory (WM) and information processing are&#xD;
      important features of schizophrenia. There is growing literature that cognitive remediation&#xD;
      therapy (CRT) can produce modest improvements in cognitive functioning in schizophrenia,&#xD;
      suggesting that systematic efforts at improving cognitive functioning are feasible. Cognitive&#xD;
      improvement after CRT may correlate with changes in brain activation patterns in specific&#xD;
      areas.&#xD;
&#xD;
      After screening, patients are randomized to a 12 week trial of CRT using COGPACK (Marker&#xD;
      Software), or to a 12-week control condition. All patients attend 3 weekly 1-hour laboratory&#xD;
      sessions, with 1 discussion session per week.&#xD;
&#xD;
      Patients continue their antipsychotic treatment with a typical or atypical antipsychotic&#xD;
      during the CRT and 4 weeks prior to enrollment in the study (Phase A). Following Phase A they&#xD;
      receive baseline evaluations, including an cognitive activation task (N-back visual-letter&#xD;
      task) while being scanned for fMRI , MATRICS neuropsychological test battery, and&#xD;
      psychiatric, social functioning, and symptoms assessment.&#xD;
&#xD;
      Patients then enter Phase B with randomization to control or CRT for 12 weeks (36 laboratory&#xD;
      sessions). Upon successful completion of 36 sessions, endpoint evaluations include an N-back&#xD;
      task while fMRI scan, MATRICS, psychiatric, and social functional assessments.&#xD;
&#xD;
      All baseline and endpoint fMRI scans are conducted at the Center for Advanced Brain Imaging&#xD;
      (CABI) at Nathan Kline Institute for Psychiatric Research.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activation changes after stimulation with a neurocognitive task in the dorso-lateral prefrontal cortex (DLPFC)</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Examine the relationship of changes in DLPFC activation patterns in relation to improvement on neurocognitive tests</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Active Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>7 patients were assigned to Cognitive Remediation Therapy..</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>4 patients were assigned to Control group or no cognitive remediation therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive remediation therapy</intervention_name>
    <description>36 sessions of computerized cognitive skills training over a 12 week duration. 7 patients were assigned to cognitive remediation therapy or CRT Group.</description>
    <arm_group_label>Active Group</arm_group_label>
    <other_name>CRT Group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inpatient status&#xD;
&#xD;
          -  Age 18 - 55&#xD;
&#xD;
          -  Male gender (females are enrolled but will not be scanned)&#xD;
&#xD;
          -  DSM-IV diagnosis of schizophrenia (all subtypes) and schizoaffective disorder&#xD;
&#xD;
          -  illness duration &gt; 5 years&#xD;
&#xD;
          -  MMSE score &gt; 24 (inclusive) at screening&#xD;
&#xD;
          -  Stable dose of oral atypical antipsychotic for at least 4 weeks prior to study entry&#xD;
&#xD;
          -  Total PANSS score &gt; 60 at screening&#xD;
&#xD;
          -  Capacity and willingness to give written informed consent&#xD;
&#xD;
          -  Patients deemed not ready to be discharged within the next 12 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to read or speak English&#xD;
&#xD;
          -  Documented disease of the central nervous system&#xD;
&#xD;
          -  History of intellectual impairment pre-dating onset of symptoms of psychosis (e.g.&#xD;
             mental retardation)&#xD;
&#xD;
          -  Clinically significant or unstable cardiovascular, renal, hepatic, gastrointestinal,&#xD;
             pulmonary, or hematological conditions; HIV positive&#xD;
&#xD;
          -  Any medical condition rendering the subject unable to receive an fMRI scan&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saurabh Kaushik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Manhattan Psychaitric Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Pierre Lindenmayer, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Manhattan Psychiatric Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan McGurk, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Dartmouth College, Hanover</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Craig A. Branch, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Center for Advanced Brain Imaging, NKI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Manhattan Psychiatric Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fmrib.ox.ac.uk/fsl/</url>
    <description>FMRIB Software Library</description>
  </link>
  <link>
    <url>http://en.wikipedia.org/wiki/Functional_magnetic_resonance_imaging</url>
    <description>Wikipedia entry for fMRI</description>
  </link>
  <reference>
    <citation>Wykes T, Reeder C, Corner J, Williams C, Everitt B. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr Bull. 1999;25(2):291-307.</citation>
    <PMID>10416732</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>February 2, 2007</study_first_submitted>
  <study_first_submitted_qc>February 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2007</study_first_posted>
  <last_update_submitted>October 2, 2020</last_update_submitted>
  <last_update_submitted_qc>October 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Manhattan Psychiatric Center</investigator_affiliation>
    <investigator_full_name>Jean-Pierre Lindenmayer</investigator_full_name>
    <investigator_title>Clinical Director</investigator_title>
  </responsible_party>
  <keyword>fMRI</keyword>
  <keyword>working memory</keyword>
  <keyword>schizophrenia</keyword>
  <keyword>treatment refractory</keyword>
  <keyword>cognitive skills training</keyword>
  <keyword>dorsolateral prefrontal cortex</keyword>
  <keyword>cognitive remediation</keyword>
  <keyword>treatment refractory schizophrenia of &gt; 5 years duration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

